13F 申報指南13F 觀念全攻略
什麼是 SEC Form 13F 申報？美股機構大戶持股全攻略
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
AlphaSMO 權威研究指南閱讀專題
CIK: 0001697013
申報總市值
US$19.3億
US$19.3億
107 檔
33.0%
Q4 2025 季度申報顯示，Eversept Partners, LP 揭露的美股組合總市值為 US$19.3億，涵蓋 107 個不同之權益投資部位。
在 Q4 2025，Eversept Partners, LP 操作展現出積極擴展與加碼意向。本季共新建倉 38 個新部位，並對 37 個既有持股進行加碼（合計增持 75 檔），相較減碼與清倉部位顯著佔優。
整體而言，Eversept Partners, LP 的前 5 大持股（包含 VERA, QQQ, GSK）貢獻了組合市值的 33.0%，形成該機構在 Q4 2025 季度的基本面基石。
| # | 代號 | 標的名稱 | 資產子類別 | 佔比 | 佔比變動 | 持倉量變化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | VERA | Vera Therapeutics Inc | 股票-其他 | 7.84% | +0.32% | +9.42% | |
| 2 | QQQ | Invesco Qqq Trust Series 1 | ETF-科技型 | 6.97% | -3.49% | -2.17% | |
| 3 | GSK | Gsk Plc-spon Adr | 股票-醫療保健 | 6.62% | -3.89% | +26.38% | |
| 4 | UTHR | United Therapeutics CORP | 股票-醫療保健 | 6.20% | -0.17% | -6.25% | |
| 5 | ABVX | Abivax Sa-adr | 股票-其他 | 4.47% | +0.83% | +54.24% | |
| 6 | NTRA | Natera Inc | 股票-醫療保健 | 3.86% | -1.58% | -35.63% | |
| 7 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 3.51% | -0.38% | -4.41% | |
| 8 | VRDN | Viridian Therapeutics Inc | 股票-其他 | 2.79% | +0.05% | -7.38% | |
| 9 | PCVX | Vaxcyte Inc | 股票-其他 | 2.78% | -0.93% | -15.77% | |
| 10 | TVTX | Travere Therapeutics Inc | 股票-其他 | 2.26% | +1.50% | -17.09% | |
| 11 | HCA | Hca Healthcare Inc | 股票-醫療保健 | 2.26% | +0.01% | -14.17% | |
| 12 | DHR | Danaher CORP | 股票-醫療保健 | 2.15% | — | +87.63% | |
| 13 | IONS | Ionis Pharmaceuticals Inc | 股票-醫療保健 | 2.15% | +0.23% | -0.08% | |
| 14 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.96% | +0.46% | +24.33% | |
| 15 | BRKR | Bruker CORP | 股票-醫療保健 | 1.86% | +0.35% | +14.07% | |
| 16 | AVTR | Avantor Inc | 股票-醫療保健 | 1.83% | -1.23% | EXIT | |
| 17 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-大型股與成長 | 1.54% | -3.67% | EXIT | |
| 18 | CYH | Community Health Systems Inc | 股票-其他 | 1.25% | +0.01% | +14.30% | |
| 19 | EXK | Exact Sciences CORP | 股票-原物料 | 1.24% | — | — | |
| 20 | BCRX | Biocryst Pharmaceuticals Inc | 股票-其他 | 1.18% | -0.56% | +117.88% | |
| 21 | GERN | Geron CORP | 股票-其他 | 1.17% | -0.24% | +40.17% | |
| 22 | TECH | Bio-techne CORP | 股票-醫療保健 | 1.12% | -0.28% | -36.20% | |
| 23 | CDTX | Cidara Therapeutics Inc | 股票-其他 | 1.10% | — | — | |
| 24 | PODD | Insulet CORP | 股票-醫療保健 | 1.07% | -0.41% | +63.82% | |
| 25 | BBNX | Beta Bionics Inc | 股票-其他 | 1.04% | +0.27% | — | |
| 26 | TEVA | Teva Pharmaceutical-sp Adr | 股票-醫療保健 | 1.04% | — | -51.59% | |
| 27 | UNH | Unitedhealth Group Inc | 股票-醫療保健 | 1.01% | +0.53% | -3.12% | |
| 28 | TLT | Ishares 20+ Year Treasury Bd | ETF-政府公債 | 1.01% | -1.96% | EXIT | |
| 29 | LQDA | Liquidia CORP | 股票-其他 | 0.89% | +0.42% | +4.82% | |
| 30 | ICLR | ICON Public Limited Company | 股票-醫療保健 | 0.88% | -0.40% | EXIT | |
| 31 | HQY | Healthequity Inc | 股票-醫療保健 | 0.86% | -0.23% | EXIT | |
| 32 | GKOS | Glaukos CORP | 股票-醫療保健 | 0.84% | -0.13% | — | |
| 33 | RVTY | Revvity Inc | 股票-醫療保健 | 0.79% | +0.09% | -58.72% | |
| 34 | NAMS | NewAmsterdam Pharma Company N.V. | 股票-其他 | 0.74% | — | -13.87% | |
| 35 | ESPR | Esperion Therapeutics Inc | 股票-其他 | 0.72% | -0.25% | EXIT | |
| 36 | BIIB | Biogen Inc | 股票-醫療保健 | 0.69% | — | +50.57% | |
| 37 | SEM | Select Medical Holdings CORP | 股票-其他 | 0.68% | — | — | |
| 38 | CNC | Centene CORP | 股票-醫療保健 | 0.67% | -0.19% | EXIT | |
| 39 | CGON | Cg Oncology Inc | 股票-其他 | 0.65% | — | — | |
| 40 | BMY | Bristol-myers Squibb Co | 股票-醫療保健 | 0.64% | — | — | |
| 41 | PALI | Palisade Bio Inc | 股票-其他 | 0.64% | -0.01% | — | |
| 42 | ARQT | Arcutis Biotherapeutics Inc | 股票-其他 | 0.64% | -0.54% | +289.93% | |
| 43 | PHVS | Pharvaris N.V. | 股票-其他 | 0.61% | +0.08% | — | |
| 44 | XBI | Ss Spdr S&p Biotech ETF | ETF-科技型 | 0.61% | +0.05% | — | |
| 45 | LLY | Eli Lilly & Co | 股票-醫療保健 | 0.58% | +0.33% | — | |
| 46 | EHC | Encompass Health CORP | 股票-醫療保健 | 0.57% | +4.39% | — | |
| 47 | CTMX | Cytomx Therapeutics Inc | 股票-其他 | 0.54% | -0.10% | — | |
| 48 | ELV | Elevance Health Inc | 股票-醫療保健 | 0.53% | — | -32.87% | |
| 49 | MNKD | Mannkind CORP | 股票-其他 | 0.53% | — | -9.31% | |
| 50 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 0.52% | +0.22% | — |
| # | 代號 | 標的名稱 | 佔比變動 | 持倉量變化 | 異動類型 |
|---|---|---|---|---|---|
| 1 | VERA | Vera Therapeutics Inc | +2.2% | +9.42% | 加碼 |
| 2 | ABVX | Abivax Sa-adr | +2% | +54.24% | 加碼 |
| 3 | AVTR | Avantor Inc | +1% | +243.63% | 加碼 |
| 4 | DHR | Danaher CORP | +0.8% | +87.63% | 加碼 |
| 5 | HQY | Healthequity Inc | +0.5% | +254.54% | 加碼 |
| 6 | ARQT | Arcutis Biotherapeutics Inc | +0.5% | +289.93% | 加碼 |
| 7 | BCRX | Biocryst Pharmaceuticals Inc | +0.5% | +117.88% | 加碼 |
| 8 | PNTG | Pennant Group Inc/the | +0.4% | +673.99% | 加碼 |
| 9 | BRKR | Bruker CORP | +0.3% | +14.07% | 加碼 |
| 10 | GSK | Gsk Plc-spon Adr | +0.3% | +26.38% | 加碼 |
| 11 | MOH | Molina Healthcare Inc | +0.3% | +380.15% | 加碼 |
| 12 | ICLR | ICON Public Limited Company | +0.2% | +74.16% | 加碼 |
| 13 | BIIB | Biogen Inc | +0.2% | +50.57% | 加碼 |
| 14 | LQDA | Liquidia CORP | +0.1% | +4.82% | 加碼 |
| 15 | GPCR | Structure Therapeutics Inc | +0.1% | -23.34% | 減碼 |
| 16 | CNC | Centene CORP | +0.1% | +44.33% | 加碼 |
| 17 | HUM | Humana Inc | +0.1% | +94.94% | 加碼 |
| 18 | TYRA | Tyra Biosciences Inc | +0.1% | +2.15% | 加碼 |
| 19 | IVVD | Invivyd Inc | +0.1% | +4.54% | 加碼 |
| 20 | PODD | Insulet CORP | +0.1% | +63.82% | 加碼 |
| 21 | ISRG | Intuitive Surgical Inc | +0.1% | +25.20% | 加碼 |
| 22 | FTRE | Fortrea Holdings Inc | +0.1% | +2.17% | 加碼 |
| 23 | MRVI | Maravai Lifesciences Hldgs-a | +0.1% | +147.21% | 加碼 |
| 24 | RLAY | Relay Therapeutics Inc | 0% | +2.10% | 加碼 |
| 25 | SRZN | Surrozen Inc | 0% | +23.75% | 加碼 |
| 26 | EHTH | Ehealth Inc | 0% | +73.45% | 加碼 |
| 27 | CBLL | Ceribell Inc | 0% | — | 不變 |
| 28 | DVAX | Dynavax Technologies CORP | — | -12.62% | 減碼 |
| 29 | ACAD | Acadia Pharmaceuticals Inc | — | +7.52% | 加碼 |
| 30 | RVP | Retractable Technologies Inc | — | +59.89% | 加碼 |
| 31 | GERN | Geron CORP | 0% | +40.17% | 加碼 |
| 32 | ZBIO | Zenas Biopharma Inc | 0% | -23.77% | 減碼 |
| 33 | BVS | Bioventus Inc - A | 0% | +8.60% | 加碼 |
| 34 | AVR | Anteris Technologies Global | 0% | — | 不變 |
| 35 | PLRX | Pliant Therapeutics Inc | 0% | +2.11% | 加碼 |
| 36 | CTNM | Contineum Therapeutics Inc-a | 0% | +2.13% | 加碼 |
| 37 | ARDX | Ardelyx Inc | 0% | +19.99% | 加碼 |
| 38 | BCYC | Bicycle Therapeutics Plc-adr | 0% | -7.98% | 減碼 |
| 39 | CPRX | Catalyst Pharmaceuticals Inc | -0.1% | +2.10% | 加碼 |
| 40 | VRDN | Viridian Therapeutics Inc | -0.1% | -7.38% | 減碼 |
| 41 | TVTX | Travere Therapeutics Inc | -0.1% | -17.09% | 減碼 |
| 42 | IFRX | InflaRx N.V. | -0.1% | +1.54% | 加碼 |
| 43 | AMRN | Amarin CORP PLC -adr | -0.1% | +2.94% | 加碼 |
| 44 | NVAX | Novavax Inc | -0.1% | -25.48% | 減碼 |
| 45 | CLDX | Celldex Therapeutics Inc | -0.1% | +24.33% | 加碼 |
| 46 | EWTX | Edgewise Therapeutics Inc | -0.1% | -32.83% | 減碼 |
| 47 | SNDX | Syndax Pharmaceuticals Inc | -0.2% | -4.41% | 減碼 |
| 48 | RAPP | Rapport Therapeutics Inc | -0.2% | -58.74% | 減碼 |
| 49 | ALEC | Alector Inc | -0.2% | -32.41% | 減碼 |
| 50 | NAMS | NewAmsterdam Pharma Company N.V. | -0.2% | -13.87% | 減碼 |
根據 SEC 官方 Form 13F 申報備案，Eversept Partners, LP 在 Q4 2025 季度的美股持倉總市值約為 US$19.3億，共申報了 107 個公開持股部位。
在 Q4 2025 季度，Eversept Partners, LP 按市值排列的前三大核心持股分別為：VERA (7.8%)、QQQ (7.0%)、GSK (6.6%)。其中最大持股部位 VERA 佔據整體投資組合約 7.8% 的權重。
精選 AlphaSMO 大戶持股與內部人交易深度分析，提升投資決策勝率
完整解讀 Form 13F 申報規範、1 億美元門檻與 45 天延遲申報機制，學會如何追蹤頂級對沖基金與機構法人持倉動向。
本季最大新建倉標的
SPY
市值: US$3061.8萬
本季最大獲利了結 / 清倉標的
ZIMV
前期市值: US$3938.3萬
在 Q4 2025 季度中，Eversept Partners, LP 共進行了 121 項持倉異動，包含新建倉 38 個部位、加碼 37 個部位、減碼 30 個部位以及清倉 16 個部位。 其中最大新建倉標的為 SPY。 本季清倉部位包含 ZIMV。
本頁面所有持股數據均直接同步自美國證券交易委員會（SEC）EDGAR 官方系統之 13F-HR / 13F-HR/A 季度申報文件。AlphaSMO 透過機器解析 CUSIP 與個股對照，提供 100% 精準對齊的歷史時序數據集，並支援 Schema.org 結構化資料格式。
解析公司高管、董事與 10% 大股東之 Form 4 內部人交易申報，掌握高管自家股票買賣第一手訊號。
深入剖析 5% 股益申報門檻、13D 與 13G 之差異，以及最新 SEC 申報時程規範，洞察機構法人的激進投資動向。